Skip to main navigation Skip to search Skip to main content

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

  • M. W. Schuster
  • , E. Anaissie
  • , D. Hurd
  • , W. Bensinger
  • , J. Mason
  • , J. McCarty
  • , R. Rifkin
  • , R. Maziarz
  • , Y. Halvorsen
  • , V. Annino
  • , W. Hahne

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)58-59
Number of pages2
JournalJournal of Supportive Oncology
Volume5
Issue number4 SUPPL. 2
StatePublished - Apr 2007

Fingerprint

Dive into the research topics of 'Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis'. Together they form a unique fingerprint.

Cite this